disease & medicine, neuroscience

A zebrafish model of the birth defect craniosynostosis provides insights into how the condition develops.

Tau proteins disrupt the movement of molecules into and out of neuronal cells’ nuclei.

Studies have demonstrated that magnetic and electrical currents can enhance memory in human subjects, but the technology is not yet ready for prime time.

The neurodegenerative disease shares protein clumps in common with appendixes, perhaps explaining why removing the organ is protective.

Precisely timed electrical stimulation and intensive rehabilitation restore some capacity to walk among three men more than four years after their debilitating injuries.

Activity in the lateral prefrontal cortex was the best correlate of weight loss in a study of people on a restricted-calorie diet.

In a condition called mechanical allodynia, when everyday activities exact misery, the same neurons that ordinarily transmit normal touch are involved in feelings of pain.

Inflammation may be a strong contender for the connection between mom’s weight and children’s neurodevelopment, according to lab studies on animals.

One variant limited the brain’s ability to use glucose.

Boosting both neurogenesis and a brain-derived growth factor can mimic the cognitive benefits of exercise in a mouse mode of Alzheimer’s disease.

A study compares verbal and math test scores to air quality measurements in China and finds a correlation.

Rosehip neurons are not found in rodents. Perhaps they offer clues about what separates our brains from those of other animals.

NIDA pharmacologist Michael Baumann explains how “unscrupulous vendors” hijacked compounds used in neuroscience and turned them into dangerous drugs.

A double gene-transfer therapy transformed the non-neuronal cells into rod photoreceptors in the retinas of animal models of congenital blindness.

Humans might also inherit such brain changes, a new study suggests.

In a clinical trial, patients on the highest injected dose had 30 percent less cognitive decline over time than people on a placebo.

A Phase 1 clinical trial shows the noninvasive technique is safe and could aid in the delivery treatments to the brain.

Researchers silence pain neurons in the mouse spinal cord with injections of botulinum toxins modified to bind to the neurons’ receptors.

In a longitudinal study, researchers find that elderly people with higher pressure were more likely to show signs of Alzheimer’s disease in brain tissue.